Huntsman Ronald Kirk 5
5 · Vivos Therapeutics, Inc. · Filed Feb 14, 2022
Insider Transaction Report
Form 5
Huntsman Ronald Kirk
DirectorChief Executive Officer10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2021-06-16$5.64/sh+125,000$705,000→ 125,000 totalExercise: $5.64Exp: 2026-06-26→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]An option for the purchase of 125,000 shares was granted on June 16, 2021. The option vests one fifth immediately and one-fifth annually on each anniversary date through June 16, 2025.